These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons. Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638 [TBL] [Abstract][Full Text] [Related]
5. Minor retinal degeneration in Parkinson's disease. Huang YM; Yin ZQ Med Hypotheses; 2011 Feb; 76(2):194-6. PubMed ID: 20933338 [TBL] [Abstract][Full Text] [Related]
6. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease. Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077 [TBL] [Abstract][Full Text] [Related]
8. TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF. Nam JH; Park ES; Won SY; Lee YA; Kim KI; Jeong JY; Baek JY; Cho EJ; Jin M; Chung YC; Lee BD; Kim SH; Kim EG; Byun K; Lee B; Woo DH; Lee CJ; Kim SR; Bok E; Kim YS; Ahn TB; Ko HW; Brahmachari S; Pletinkova O; Troconso JC; Dawson VL; Dawson TM; Jin BK Brain; 2015 Dec; 138(Pt 12):3610-22. PubMed ID: 26490328 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
11. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells. Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421 [TBL] [Abstract][Full Text] [Related]
12. Role of chemokines in Parkinson's disease. Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787 [TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068 [TBL] [Abstract][Full Text] [Related]
14. LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila. Marcogliese PC; Abuaish S; Kabbach G; Abdel-Messih E; Seang S; Li G; Slack RS; Haque ME; Venderova K; Park DS Hum Mol Genet; 2017 Apr; 26(7):1247-1257. PubMed ID: 28158614 [TBL] [Abstract][Full Text] [Related]
15. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
16. Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice. Le W; Zhang L; Xie W; Li S; Dani JA Neurobiol Aging; 2015 Dec; 36(12):3314-3320. PubMed ID: 26363812 [TBL] [Abstract][Full Text] [Related]
17. Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease. Hernandez-Chan NG; Bannon MJ; Orozco-Barrios CE; Escobedo L; Zamudio S; De la Cruz F; Gongora-Alfaro JL; Armendáriz-Borunda J; Reyes-Corona D; Espadas-Alvarez AJ; Flores-Martínez YM; Ayala-Davila J; Hernandez-Gutierrez ME; Pavón L; García-Villegas R; Nadella R; Martinez-Fong D J Biomed Sci; 2015 Jul; 22(1):59. PubMed ID: 26198255 [TBL] [Abstract][Full Text] [Related]